Teratogenic Mechanisms Associated with Prenatal Medication Exposure

被引:12
|
作者
van Gelder, Marleen M. H. J. [1 ]
van Rooijl, Iris A. L. M. [1 ]
de Jong-van den Berg, Lolkje T. W. [2 ]
Roeleveld, Nel [1 ,3 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6500 HB Nijmegen, Netherlands
[2] Univ Groningen, SHARE, Dept Pharmacoepidemiol & Pharmacoecon, Groningen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands
来源
THERAPIE | 2014年 / 69卷 / 01期
关键词
congenital abnormalities; pharmaceutical agents; pregnancy; teratology; NEURAL-TUBE DEFECTS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HISTONE-DEACETYLASE INHIBITORS; SEROTONIN-REUPTAKE INHIBITORS; FOLIC-ACID ANTAGONISTS; PROSTAGLANDIN-H SYNTHASE; CULTURED RAT EMBRYOS; METHYL-D-ASPARTATE; OXIDATIVE STRESS; RETINOIC ACID;
D O I
10.2515/therapie/2014003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Birth defects may originate through multiple mechanisms and may be caused by a variety of possible exposures, including medications in early pregnancy. In this review, we describe six principal teratogenic mechanisms suspected to be associated with medication use: folate antagonism, neural crest cell disruption, endocrine disruption, oxidative stress, vascular disruption, and specific receptor-or enzyme-mediated teratogenesis. Knowledge about these mechanisms, for some of which evidence is mainly derived from animal models, may not only be relevant for etiologic and post-marketing research, but may also have implications for prescribing behavior for women of reproductive age. Since combinations of seemingly unrelated medications may have effects through similar teratogenic mechanisms, the risk of birth defects may be strongly increased in multi-therapy.
引用
收藏
页码:13 / 24
页数:12
相关论文
共 50 条
  • [31] Prenatal psychotropic medication exposure alters acute neonatal pain response
    Oberlander, TF
    Grunau, RE
    Fitzgerald, CE
    Misri, S
    Riggs, W
    PEDIATRIC RESEARCH, 2000, 47 (04) : 31A - 31A
  • [32] EPENDYMOBLASTOMA ASSOCIATED WITH PRENATAL EXPOSURE TO DIPHENYLHYDANTOIN AND METHYLPHENOBARBITONE
    LIPSON, A
    BALE, P
    CANCER, 1985, 55 (09) : 1859 - 1862
  • [33] Infant Mortality Associated With Prenatal Opioid Exposure
    Leyenaar, JoAnna K.
    Schaefer, Andrew P.
    Wasserman, Jared R.
    Moen, Erika L.
    O'Malley, A. James
    Goodman, David C.
    JAMA PEDIATRICS, 2021, 175 (07) : 706 - 714
  • [34] Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors
    Burdan, F
    Szumilo, J
    Dudka, J
    Agnieszka, KC
    Klepacz, R
    PHARMACOLOGICAL RESEARCH, 2006, 53 (03) : 287 - 292
  • [35] Is prenatal alcohol exposure associated with childhood overweight?
    Li, CY
    Kaur, H
    Choi, WS
    Ahluwalia, JS
    CIRCULATION, 2004, 109 (07) : E138 - E138
  • [36] Prenatal Exposure to Misoprostol and Associated Congenital Malformations
    Garcia-Robles, Reggie
    Suarez-Obando, Fernando
    Catalina Lopez, Maria
    Zarante Montoya, Ignacio
    UNIVERSITAS MEDICA, 2016, 57 (02): : 226 - 235
  • [37] THE GENITAL ANOMALY ASSOCIATED WITH PRENATAL EXPOSURE TO PROGESTOGENS
    JONES, HW
    WILKINS, L
    FERTILITY AND STERILITY, 1960, 11 (02) : 148 - 156
  • [38] ABNORMALITIES IN OFFSPRING ASSOCIATED WITH PRENATAL MARIHUANA EXPOSURE
    QAZI, QH
    MARIANO, E
    MILMAN, DH
    BELLER, E
    CROMBLEHOLME, W
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1985, 8 (02): : 141 - 148
  • [39] HEALTH RISKS ASSOCIATED WITH PRENATAL METAL EXPOSURE
    ZELIKOFF, JT
    BERTIN, JE
    BURBACHER, TM
    HUNTER, ES
    MILLER, RK
    SILBERGELD, EK
    TABACOVA, S
    ROGERS, JM
    FUNDAMENTAL AND APPLIED TOXICOLOGY, 1995, 25 (02): : 161 - 170
  • [40] PSYCHIATRIC CONDITIONS ASSOCIATED WITH PRENATAL ALCOHOL EXPOSURE
    O'Connor, Mary J.
    Paley, Blair
    DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2009, 15 (03) : 225 - 234